Head of Digital Technologies & Innovation
Landmark Bio
Shanti Chari has a blend of biotech/pharma industry and consulting experience for 20+ years. Currently she heads “Digital Technologies and Innovation” at Landmark Bio. More recently, she worked with Emergent and Amgen and was responsible for digital strategy and deployments in manufacturing, quality and supply chain space. Her major stints in consulting include Deloitte and The Hackett Group